Delta vs Illumina Which Should You Buy?
Delta and Illumina are two prominent companies in the technology and healthcare sectors, respectively. Delta is known for its innovative solutions in the aviation industry, while Illumina specializes in genetic sequencing and analysis. Both companies have seen fluctuations in their stock prices, with Delta affected by shifts in the travel industry and Illumina influenced by advancements in healthcare technology. Investors are keenly watching the performance of these stocks as they navigate through challenging market conditions.
Delta or Illumina?
When comparing Delta and Illumina, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Delta and Illumina.
Dividend Investors:
Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company.
Delta has a dividend yield of 1.07%, while Illumina has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Delta reports a 5-year dividend growth of 4.56% year and a payout ratio of 0.00%. On the other hand, Illumina reports a 5-year dividend growth of 0.00% year and a payout ratio of 0.00%.
Value Investors:
Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Delta P/E ratio at 20.03 and Illumina's P/E ratio at -14.66. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Delta P/B ratio is 1.22 while Illumina's P/B ratio is 9.53.
Growth Investors:
Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Delta has seen a 5-year revenue growth of 0.17%, while Illumina's is 0.26%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Delta's ROE at 6.26% and Illumina's ROE at -41.29%.
Retail Investors:
Retail investors often consider stock affordability and company familiarity. For example, day low prices are ₹116.00 for Delta and $145.22 for Illumina. Over the past year, Delta's prices ranged from ₹104.45 to ₹159.80, with a yearly change of 52.99%. Illumina's prices fluctuated between $90.17 and $156.66, with a yearly change of 73.75%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.